Related Experiment Video
Updated: Jan 26, 2026

Acupuncture in a Rat Model of Asthma
Published on: August 25, 2020
Cytokines and Chemokines as Biomarkers of Future Asthma
1Departments of Paediatrics and Paediatric Respiratory Medicine, Royal Brompton Harefield NHS Foundation Trust and Imperial College, London, United Kingdom.
Insights
Early structural airway changes, not just inflammation, predict childhood asthma. Understanding early immune responses to microbes and viruses is key to preventing pediatric wheeze and asthma.
Area of Science:
- Pediatric Respiratory Medicine
- Immunology
- Microbiome Research
Background:
- Childhood asthma development involves complex interactions between genetic predisposition, environmental exposures, and immune system maturation.
- Traditionally, eosinophilic asthma was viewed as primarily driven by airway inflammation, but recent evidence suggests parallel processes including structural changes and hyper-responsiveness.
- Early life factors, including antenatal and preschool influences, are critical in determining the trajectory towards pre-school wheeze and later eosinophilic asthma.
Purpose of the Study:
- To elucidate the earliest events and underlying mechanisms driving the progression from pre-school wheeze to eosinophilic asthma.
- To investigate the roles of structural airway changes, immune dysregulation, viral and bacterial infections, and the microbiome in early respiratory disease development.
- To identify key cytokine and chemokine signals from bronchial epithelial cells that initiate these processes.
Main Methods:
- Review and synthesis of existing literature on antenatal and preschool factors influencing respiratory outcomes.
- Analysis of the interplay between airway structural remodeling, inflammation, infection, and immune responses.
- Examination of the impact of viral and bacterial infections, and the airway and gut microbiome on immune development and asthma pathogenesis.
Main Results:
- Very early structural airway changes, independent of inflammation, are linked to airway hyper-responsiveness and adverse respiratory outcomes.
- Both viral and bacterial infections play significant roles, with early bacterial colonization potentially indicating immune deficiency.
- The airway and gut microbiome critically influence Type 2 inflammatory responses, but Type 2 cytokines are not implicated in the very early disease development.
Conclusions:
- The earliest pathogenic signals in asthma development likely originate from bronchial epithelial cell function and their interactions with viruses and the microbiome.
- A paradigm shift is needed, recognizing parallel processes of structural changes, inflammation, and hyper-responsiveness from the earliest stages.
- Targeting early epithelial cell responses and microbial interactions may offer novel strategies for preventing pediatric asthma.
Abstract:
Antenatal and preschool factors are key in determining the progression to pre-school wheeze and eosinophilic school age asthma. The conventional view of eosinophilic asthma is that airway inflammation is the fundamental underlying abnormality, and airway inflammation and hyper-responsiveness are secondary; in fact, these three are parallel processes. Very early structural changes, independent of inflammation and infection, are associated with early airway hyper-responsiveness and later adverse respiratory outcomes. There is a bidirectional relationship between structural airway wall changes and airway inflammation, with airway contraction per se leading to the release of growth factors, and inflammatory pathways promoting airway remodeling. Early viral infection (and increasingly being appreciated, bacterial infection) is important in wheeze outcomes. There is evidence of abnormal immune function including cytokine release before the onset of viral infections. However, viral infections may also have prolonged effects on the host immune system, and the evidence for beneficial and adverse effects of viral infection is conflicting. In older children and adults, asthmatic epithelial cells show impaired interferon responses to viral infection, but only in the presence of uncontrolled type 2 inflammation, implying these are secondary phenomena. There are also compelling data relating the innate immune system to later asthma and atopy, and animal studies suggest that the effects of a high endotoxin, microbiologically diverse environment may be modulated via the epithelial alarmin IL-33. Whereas, previously only viral infection was thought to be important, early bacterial colonization of the upper airway is coming to the fore, associated with a mixed pattern of TH1/TH2/TH17 cytokine secretion, and adverse long term outcomes. Bacterial colonization is probably a marker of a subtle immune deficiency, rather than directly causal. The airway and gut microbiome critically impacts the development of Type 2 inflammatory responses. However, Type 2 inflammatory cytokines, which are critical both to progression from pre-school wheeze to eosinophilic asthma, and sustaining the eosinophilic asthmatic state, are not implicated in the very early development of the disease. Taken together, the evidence is that the earliest cytokine and chemokine signals will come from the study of bronchial epithelial cell function and their interactions with viruses and the microbiome.
Related Concept Videos
Asthma-I: Introduction
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-III: Symptoms and Complications
Classification of Asthma
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-IV: Nursing Management
First, in...

